Nyumbani › Limfoma ya Selu Kubwa za B Diffuse › Missouri › St. Louis
Majaribio ya kliniki ya Limfoma ya Selu Kubwa za B Diffuse katika St. Louis, MO
Masomo 8 ya Limfoma ya Selu Kubwa za B Diffuse yanatafuta washiriki katika vituo vya St. Louis na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
InaajiriHatua 2
- Washington University School of Medicine - Siteman Cancer Center, St Louis
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
InaajiriHatua 2
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- na zaidi ya 2
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
InaajiriHatua 3
- Circuit Clinical - SSM Health Cancer Care DePaul ( Site 0166), Bridgeton · Mi 15 mbali
- Cancer Care Specialists of Illinois ( Site 0152), O'Fallon · Mi 16 mbali
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
InaajiriHatua 2
- Cancer Care Specialists of Central Illinois, Swansea · Mi 13 mbali
CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
InaajiriHatua 2
- Washington University School of Medicine, St Louis
DALY II USA/ MB-CART2019.1 for DLBCL
InaajiriHatua 2
- Washington University, St. Louis, St Louis
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
InaajiriHatua 2
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- na zaidi ya 2
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
InaajiriHatua 2
- Siteman Cancer Center at Washington University, St Louis
Majaribio ya Limfoma ya Selu Kubwa za B Diffuse katika miji mingine
- New York City, NYUtafiti 21
- Baldwin Park, CAUtafiti 19
- Chicago, ILUtafiti 18
- Houston, TXUtafiti 17
- Los Angeles, CAUtafiti 17
- Boston, MAUtafiti 16
- Milwaukee, WIUtafiti 16
- Nashville, TNUtafiti 15
- Portland, ORUtafiti 15
- Philadelphia, PAUtafiti 15
- Durham, NCUtafiti 14
- Dallas, TXUtafiti 13
Masomo mengine katika St. Louis
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 73
- Saratani ya MatitiUtafiti 64
- Saratani ya MetastasiUtafiti 54
- Kansari ya kolorektaliUtafiti 50
- Saratani ya ProstateUtafiti 46
- Saratani (aina zote)Utafiti 46
- Saratan ya MapafuUtafiti 39
- Kansari ya MayaiUtafiti 38
- Kansari ya PancreasUtafiti 33
- Saratani ya EndometrialUtafiti 29
- Kansari ya Seluli za Skwamu za Kichwa na ShingoUtafiti 28
- Kushindwa kwa MoyoUtafiti 26
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.